Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.
Anit-angiogenic - immunotherapy combination represents new treatment option for recurrent ovarian cancer.
Dr John Stricker discusses what the recent data from "Circulate" tells us about integrating MRD assays into clinical practice?
Post ESMO Update on IMPower Clinical Trial in Early Stage NSCLC
Innovative Clinical Trials for Lung Cancer Currently Underway
Advances in the Management of Advanced Colorectal Cancer – A Case Based Discussion
Dr. Birrer M.D. of Mass General Hospital answers common questions about clinical trials for ovarian cancer.
Elderly, Minorities and Women Under-represented in Lung Cancer Clinical Trials.
Phase I/II Clinical Trial Will Assess Lung Cancer Vaccine
Clinical Trial Evaluating Myocet® for Breast Cancer Now Enrolling Patients
Certain centers specializing in treating sarcomas offer better access to clinical trials and doctors with expertise.
